Subscribe to our free educational bulletin to learn more about us and innovative ways to use patient records research! Click on the sun to register.

© 2014-2017 Clarity Pharma Research LLC  |  All Rights Reserved Privacy Policy

To learn more about our services, call (864) 208-0078 or contact

Subscribe to our newsletter at:

      Clarity Pharma newsroom 


  • ISPOR (International Society for Pharmacoeconomics and Outcomes Research): Dr. Jack R. Gallagher, Clarity Pharma Research chief scientist, was lead author of a poster presentation at the November 2015 European congress in Milan, Italy, about the use of a retrospective patient chart audit to capture economic burden evidence for a rare disease. Global Operations Director Kylee Jean Heap was a co-author.
  • EphMRA (European Pharmaceutical Market Research Association): Dr. Gallagher presented “Precedent and consequence research to undergird orphan reimbursement strategy – A multi-layered, non-traditional approach,” a presentation on building evidence packages to gain market access that he co-authored with a client, at the June 2015 EphMRA conference in Amsterdam.   
  • Urology Practice has published an article based on findings of a Clarity Pharma Research study on genomic testing and prostate cancer, with Dr. Gallagher among the co-authors.
  • Japanese Respiratory Society: Nonproprietary findings of Clarity Pharma Research’s multi-nation study of a rare lung disease were presented in a poster in April 2015 at the society’s 55th annual meeting in Tokyo. Clarity’s Dr. Gallagher was a co-author.
Please take a moment to view some of our past newsletters:
Clarity’s chief scientist to speak again at EphMRA (view) 
— Evaluating Low-Information Markets with Delphi Method (view)
— Clarity Co-Authors KIT 2014 Presentation (view)
— Our Redesigned Web Site Has You in Mind (view)
— Why Peer-Reviewed Publications Matter (view)
— Meet the Elephant: Faster, Cheaper, Better? (view)
How Does Your Drug / Device Stack Up? Comparative Cost-
​     Effectiveness Research 
Correcting Claims Data with Patient Records Research  (view)
Sample Size: Sometimes Less IS More  (view)
Can Good Math Correct a Bad Study?  (view)

Is Your Market Research Costing You? (view)
Who Is Alf Landon? (And Why It Matters) (view)